化学·生活·社会
抗流感病毒药物合成研究纵览
蔡岩1 , 丁晓丽2 , 章聚宝2 , 周卫红3 , 苗志伟1,2
1. 南开大学化学学院元素有机化学国家重点实验室 天津 300071;
Survey on Anti-Influenza Drug Synthesis
CAI Yan1 , DING Xiao-Li2 , ZHANG Ju-Bao2 , ZHOU Wei-Hong3 , MIAO Zhi-Wei1,2
1. State Key Laboratory of Elemento-Organic Chemistry, College of Chemistry, Nankai University, Tianjin 300071, China;
摘要： 流行性感冒（流感）是一种传染性强和传播速度快的疾病，对人类健康构成严重威胁。为了更好地抵御流感病毒对人类健康的侵害，科学家们一直致力于新型抗流感病毒药物的研究和发现工作。针对已上市抗流感药物以及处于研发阶段的抗流感病毒抑制剂的合成方法进行概述，为抗流感药物的合成工艺研究和药物研发提供参考。
关键词： 流行性感冒 ,
流感病毒 ,
抗流感病毒药物 ,
药物合成
基金资助: 新疆维吾尔自治区自然科学基金（2016D01A016）
通讯作者:
丁晓丽, 苗志伟
E-mail: 1034358227@qq.com;miaozhiwei@nankai.edu.cn
引用本文:
蔡岩, 丁晓丽, 章聚宝, 周卫红, 苗志伟. 抗流感病毒药物合成研究纵览[J]. 化学教育（中英文）, 2019, 40(12): 5-18
[1]
王秀荣,陈化兰. 中国农业科学,2015, 48(15):3038-3039
[2]
Bedford T, Riley S, Barr I G, et al. Nature, 2015, 523(7559):217-220
[3]
Zhang Q, Zhao Q S, Xiong R S. Acta Phar. Sinica, 2010, 45(3):289-299
[4]
Ivachtchenko A V, Ivanenkov Y A, Mitkin O D. Antiviral Res., 2013, 100(3):698-708
[5]
Rey-Carrizo M, Torres E, Ma C, et al. J. Med. Chem., 2013, 56(22):9265-9274
[6]
Wu Y, Canturk B, Jo H, et al. J. Am. Chem. Soc., 2014, 136(52):17987-17995
[7]
Grinberg G M. J. Chem. Soc., 1977, 11(4):496-497
[8]
Long S S, Pickering L K, Prober C G. Elsevier Health Sciences, 2012, 1502-1503
[9]
Das A, Adak A K, Ponnapalli K, et al. Eur. J. Med. Chem., 2016, 123:397-406
[10]
Chandler M, Bamford M J, Conroy R. J. Chem. Soc. Perkin Trans., 1995(1):1173-1180
[11]
Itzstein M V, Wu W Y, Jin B. Carbohydr. Res., 1994, 259(2):301-305
[12]
Liu K G, Yan S, Wu Y L, et al. Org. Lett., 2004, 6(13):2269-2272
[13]
Tian J S, Zhong J K, Li Y S, et al. Angew. Chem. Int. Ed., 2014, 53(50):13885-13888
[14]
Andr C, Bolte J, Demuynck C. Tetrahedron:Asymmetry, 1998, 9(8):1359-1367
[15]
Honda T, Masuda T, Yoshida S, et al. Bioorg. Med. Chem. Lett., 2002, 12(15):1921-1924
[16]
Honda T, Kobayashi Y, Masuda T. Neuraminic acid derivatives, their preparation and their medical use:US6340702B1[P]. 2002-01-22
[17]
Thomson R J, von Itzstein M. Carbohydr. Res., 1995, 274(8):29-44
[18]
Kim C U, Lew W, Williams M A, et al. J. Med. Chem., 1998, 41(14):2451-2460
[19]
Rohloff J C, Kent K M, Postich M J, et al. J. Org. Chem., 1998, 63(13):4545-4547
[20]
Federspiel M, Fischer R. Org. Proc. Res. Dev., 1999, 3(4):266-274
[21]
Karpf M, Trussardi R. J. Org. Chem., 2001, 66(6):2044-2051
[22]
Harrington P J, Brown J D, Foderaro T, et al. Org. Proc. Res. Dev., 2004, 8(1):86-91
[23]
Babu Y S, Chand P, Bantia S, et al. J. Med. Chem., 2000, 43(19):3482-3486
[24]
陈卫民, 贾飞, 陈建新,等. 一种抗流感及禽流感病毒药物帕拉米韦的合成方法:中国,102372657A[P]. 2012-03-14
[25]
陈小勇,李佩杰,梁杰. 一种帕拉米韦的制备方法:中国,102633686A[P]. 2012-08-15
[26]
Cai Z W, An R C, Wang W H, et al. A novel process for the preparation of peramivir and intermediates thereof:WO2012145932A1[P]. 2012-11-01
[27]
Furuta Y, Takahashi K, Fukuda Y, et al. Antimicrob Agents Ch., 2002, 46(4):977-981
[28]
Furuta Y, Gowen B B, Takahashi K, et al. Antiviral Res., 2013, 100(2):446-454
[29]
Oestereich L, Lüdtke A, Wurr S, et al. Antiviral Res., 2014, 105(1):17-21
[30]
Egawa H, Furuta Y, Sugita, et al. Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof:US2003130213A1[P]. 2003-07-10
[31]
郑家晴,张涛,刘昌铭,等. 6-氟-3-羟基-2-吡嗪酰胺的制备方法:中国,102775358A[P]. 2012-11-14
[32]
张涛,孔令金,李宗涛,等. 中国医药工业杂志, 2013, 44(9):841-843
[33]
王欢,李行舟,钟武. 中国医药工业杂志, 2014, 45(11):1009
[34]
王皖,刘敏,肖新荣,等. 国际药学研究杂志, 2015, 42:220-224
[35]
王凯,孙新宇,姚思,等. 法匹拉韦的合成工艺:中国,106478528A[P]. 2017-03-08
[36]
Clark M P, Ledeboer M W, Davies I, et al. J. Med. Chem., 2014, 57(15):6668-6678
[37]
Tanoury G J, Nugent W A, Dvornikovs V, et al. Methods of preparing inhibitors of influenza viruses replication:WO2015073481A1[P]. 2015-05-21
[38]
Byrn R A, Jones S M, Bennett H B, et al. Antimicrobe Agents Ch., 2015, 59(3):1569-1582
[39]
Charifson P S, Clark M P. Inhibitors of influenza viruses replication:WO2013019828A1[P]. 2013-02-07
[40]
Makoto K, Kenji T, Toshiyuki A, et al. Multiple ticyclic Pyridonecarboxylic deriv. and drag substd. aggrecanase:WO2016175224[P]. 2016-11-03
[41]
Evan der Vries, Stelma F F, Boucher C A, N. Engl. J. Med., 2010, 363(14):1381-1382
[42]
Basu A, Antanasijevic A, Wang M, et al. J. Virol., 2014, 88(3):1447-1460
[43]
Basu A, Mills D M, Williams J, et al. Aminoalkyl phenol ether inhibitors of influenza A virus:WO2013074965A1[P]. 2013-05-23
[44]
Tang G Z, Lin X F, Yang W G, et al. ACS Med. Chem. Lett., 2011, 2(8):603-607
[45]
Zhu L, Li Y, Li S, et al. PLoS One, 2011, DOI:10.1371/journal.pone.0029120
[46]
Portela A, Digard P. J. Gen. Virol., 2002, 83:723-734
[47]
Kao R Y, Yang D, Lau L S, et al. Nature Biotech., 2010, 28(6):600-605
[48]
张姝, 屈博毅, 海俐, 等. 中国药物化学杂志, 2016, 26(1):1-9
[49]
Gerritz S W, Christopher C, Sean K, et al. Proc. Natl. Acad. Sci., 2011, 108(37):15366-15371
[50]
Su C Y, Cheng T J, Lin M I, et al. Proc. Natl. Acad. Sci., 2010, 107(45):19151-19156
[51]
Cheng H, Wan J, Lin M, et al. J. Med. Chem., 2012, 55(5):2144-2153
[52]
燕子红,蔡岩,李雪琼,等. 化学通报, 2018, 81(11):1015-1022
[53]
Monod A, Swale C, Tarus B, et al. Expert Opin Drug Discov., 2015, 10(4):345-371
